Skip to main content
CKD Bio Corp. logo

CKD Bio Corp. — Investor Relations & Filings

Ticker · 063160 ISIN · KR7063160006 LEI · 988400RFJ8DLB1NTOE10 KO Manufacturing
Open in API
Filings indexed 146 across all filing types
Latest filing 2019-04-01 Annual Report
Country KR South Korea
Listing KO 063160

About CKD Bio Corp.

https://www.ckdbio.com/en/home

CKD Bio Corp. is a pharmaceutical company specializing in fermentation and chemical synthesis technologies. The company develops and manufactures a range of products, including Active Pharmaceutical Ingredients (APIs), intermediates, and probiotics. Its API portfolio features fermentation-based products such as antibiotics, ß-lactamase inhibitors, and immunosuppressants. Leveraging extensive experience in fermentation, CKD Bio also produces next-generation probiotics using patented technology. Additionally, the company provides Contract Manufacturing (CMO) and Contract Research (CRO) services for APIs and intermediates, utilizing its cGMP-certified production facilities.

Recent filings

Filing Released Lang Actions
사업보고서 (2018.12)
Annual Report Classification · 100% confidence The document is a comprehensive 'Business Report' (사업보고서) for the 18th fiscal year (2018) of Chong Kun Dang Bio. It contains detailed financial statements, management discussion and analysis, auditor's opinion, and corporate governance information. This aligns with the definition of an Annual Report (10-K) as it covers company activity and full financial performance for the fiscal year. FY 2018
2019-04-01 Korean
감사보고서 (2018.12)
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report' (감사보고서) for the company 'Chong Kun Dang Bio' (주식회사 종근당바이오) for the fiscal year ending December 31, 2018. It includes the independent auditor's opinion, financial statements (balance sheet, income statement, statement of changes in equity, cash flow statement), and detailed notes to the financial statements. This is a comprehensive financial audit document, not a summary or an announcement, and fits the definition of an Audit Report (AR). FY 2018
2019-03-29 Korean
신규시설투자등
Capital/Financing Update Classification · 98% confidence The document is a regulatory disclosure regarding a new facility investment (capital expenditure) by Chong Kun Dang Bio. It details the investment amount, purpose, timeline, and board approval. Since it is a specific regulatory announcement regarding corporate capital investment and does not fit into the other specific categories like M&A or share issues, it is classified as a general regulatory filing.
2019-03-19 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a detailed breakdown of the resolutions passed during the meeting, including financial statement approval, dividend declarations, and board/auditor appointments. This falls directly under the definition of a Declaration of Voting Results & Voting Rights Announcement.
2019-03-15 Korean
감사보고서제출
Audit Report / Information Classification · 98% confidence The document is a short regulatory filing (1332 characters) titled '감사보고서 제출' (Submission of Audit Report). It provides a summary table of financial data and audit opinions for the fiscal year 2018, as required by Korean regulatory disclosure rules. According to the 'Menu vs Meal' rule, since this is a short announcement of the audit report submission rather than the full audit report document itself, it is classified as a Report Publication Announcement (RPA). FY 2018
2019-03-07 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Chong Kun Dang Bio. It contains the agenda for the 18th Annual General Meeting, including the approval of financial statements, dividend proposals, and board/auditor compensation. While it includes financial statements and audit information as part of the meeting materials, the primary purpose of this specific filing is to solicit shareholder attendance and votes for the upcoming meeting. Therefore, it is classified as a Proxy Solicitation & Information Statement.
2019-02-28 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.